why choose us

First received: April 05, 2024

Clinical Trial: Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Attention
Visual Perceptual Weakness
Social Behavior
Fluency Disorder
EEG With P

Study Type: INTERVENTIONAL


Official Title: Results of the Application of 80 Sessions of tDCS for 12 Months in Children Between 6 and 11 Years Old With Autism Spectrum Disorder With Rare Diseases, Genetic Problems or PANDAS

Brief Summary: Results of the application of 100 sessions of tDCS for 12 months in children between 6 and 11 years old with autism spectrum disorder with rare diseases, genetic problems or PANDAS

Read more